Xing Lü

649 total citations
30 papers, 529 citations indexed

About

Xing Lü is a scholar working on Oncology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Xing Lü has authored 30 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 10 papers in Molecular Biology and 8 papers in Organic Chemistry. Recurrent topics in Xing Lü's work include Metal complexes synthesis and properties (11 papers), Bioactive Compounds and Antitumor Agents (3 papers) and Ferrocene Chemistry and Applications (3 papers). Xing Lü is often cited by papers focused on Metal complexes synthesis and properties (11 papers), Bioactive Compounds and Antitumor Agents (3 papers) and Ferrocene Chemistry and Applications (3 papers). Xing Lü collaborates with scholars based in China, Canada and United States. Xing Lü's co-authors include Zhen‐Feng Chen, Yan‐Cheng Liu, Hong Liang, Chris Orvig, Hong Liang, Yanfei Xia, Kezhi Jiang, Wei Yang, Li‐Wen Xu and Qi‐Pin Qin and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Journal of Medicinal Chemistry.

In The Last Decade

Xing Lü

29 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xing Lü China 15 221 181 170 48 41 30 529
Laure Eloy France 18 275 1.2× 121 0.7× 281 1.7× 27 0.6× 5 0.1× 32 1.1k
Jelena Milovanović Serbia 15 145 0.7× 257 1.4× 193 1.1× 48 1.0× 2 0.0× 43 649
Geng Xu China 14 62 0.3× 147 0.8× 183 1.1× 7 0.1× 4 0.1× 50 585
Di Hu China 13 124 0.6× 178 1.0× 214 1.3× 28 0.6× 9 0.2× 39 544
Young Shin Cho United States 11 275 1.2× 105 0.6× 248 1.5× 20 0.4× 4 0.1× 16 445
Sushil Kumar Gupta India 10 116 0.5× 180 1.0× 181 1.1× 42 0.9× 22 486
Jing Xia China 11 68 0.3× 107 0.6× 276 1.6× 6 0.1× 3 0.1× 30 552
Ian L. Scott United States 14 396 1.8× 52 0.3× 254 1.5× 42 0.9× 4 0.1× 23 762
Mateusz Psurski Poland 15 169 0.8× 107 0.6× 220 1.3× 23 0.5× 50 579
Wing‐Sze Lee Hong Kong 14 394 1.8× 51 0.3× 92 0.5× 155 3.2× 17 0.4× 19 769

Countries citing papers authored by Xing Lü

Since Specialization
Citations

This map shows the geographic impact of Xing Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xing Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xing Lü more than expected).

Fields of papers citing papers by Xing Lü

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xing Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xing Lü. The network helps show where Xing Lü may publish in the future.

Co-authorship network of co-authors of Xing Lü

This figure shows the co-authorship network connecting the top 25 collaborators of Xing Lü. A scholar is included among the top collaborators of Xing Lü based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xing Lü. Xing Lü is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Jiaxuan, Shuzhen Liao, Xing Lü, et al.. (2025). Basophil-derived exosomes exacerbate systemic lupus erythematosus by regulating B-cell proliferation via miR-24550. BMC Medicine. 23(1). 490–490.
2.
Lü, Xing, et al.. (2023). Copper(II) complexes with plumbagin and bipyridines target mitochondria for enhanced chemodynamic cancer therapy. Journal of Inorganic Biochemistry. 251. 112432–112432. 8 indexed citations
3.
Lü, Xing, et al.. (2023). Platinum-Based Mcl-1 Inhibitor Targeting Mitochondria Achieves Enhanced Antitumor Activity as a Single Agent or in Combination with ABT-199. Journal of Medicinal Chemistry. 66(13). 8705–8716. 14 indexed citations
4.
Lü, Xing, Hong Liang, Chris Orvig, & Zhen‐Feng Chen. (2020). Peptide and Small Molecule Inhibitors Targeting Myeloid Cell Leukemia 1 (Mcl-1) as Novel Antitumor Agents. Current Molecular Medicine. 21(5). 426–439. 8 indexed citations
5.
Lü, Xing, Yan‐Cheng Liu, Chris Orvig, Hong Liang, & Zhen‐Feng Chen. (2019). Discovery of β-carboline copper(II) complexes as Mcl-1 inhibitor and in vitro and in vivo activity in cancer models. European Journal of Medicinal Chemistry. 181. 111567–111567. 29 indexed citations
6.
Xu, Lei, et al.. (2018). Long-term quality of life after sepsis and predictors of quality of life in survivors with sepsis. Chinese Journal of Traumatology. 21(4). 216–223. 10 indexed citations
7.
Kuang, Wenbin, Ri-Zhen Huang, Jiao-Lan Qin, et al.. (2018). Design, synthesis and pharmacological evaluation of new 3-(1H-benzimidazol-2-yl)quinolin-2(1H)-one derivatives as potential antitumor agents. European Journal of Medicinal Chemistry. 157. 139–150. 25 indexed citations
8.
Lü, Xing, Jian-Hua Wei, Yan‐Cheng Liu, et al.. (2018). In vitro and in vivo anti-tumor activity of two gold(III) complexes with isoquinoline derivatives as ligands. European Journal of Medicinal Chemistry. 163. 333–343. 30 indexed citations
9.
Lü, Xing, Yiming Wu, Sheng Chen, et al.. (2018). Preparation of Rhodium(III) complexes with 2(1H)-quinolinone derivatives and evaluation of their in vitro and in vivo antitumor activity. European Journal of Medicinal Chemistry. 151. 226–236. 15 indexed citations
10.
Zhang, Guohai, Liangping Li, Yang Yang, et al.. (2018). Mitochondrion‐Targeting Identification of a Fluorescent Apoptosis‐Triggering Molecule by Mass Spectrometry Elucidates Drug Tracking. ChemBioChem. 20(6). 778–784. 1 indexed citations
11.
Lü, Xing, et al.. (2017). The correlation of the depth of anesthesia and postoperative cognitive impairment: A meta-analysis based on randomized controlled trials. Journal of Clinical Anesthesia. 45. 55–59. 45 indexed citations
13.
Zhang, Guohai, Xing Lü, Hui Zhong, et al.. (2015). A Novel Naphthalimide Compound Restores p53 Function in Non-small Cell Lung Cancer by Reorganizing the Bak·Bcl-xl Complex and Triggering Transcriptional Regulation. Journal of Biological Chemistry. 291(8). 4211–4225. 32 indexed citations
14.
Yu, Bing, et al.. (2014). Frontiers in Micro-Nano Science and Technology. Trans Tech Publications Ltd. eBooks. 3 indexed citations
15.
Yang, Wei, Kezhi Jiang, Xing Lü, et al.. (2013). Molecular Assembly of an Achiral Phosphine and a Chiral Primary Amine: A Highly Efficient Supramolecular Catalyst for the EnantioselectiveMichael Reaction of Aldehydes with Maleimides. Chemistry - An Asian Journal. 8(6). 1182–1190. 32 indexed citations
16.
Yu, Bing, et al.. (2013). Leading Edge of Micro-Nano Science and Technology. Trans Tech Publications Ltd. eBooks. 2 indexed citations
17.
Lü, Xing, Li Li, Wei Yang, et al.. (2013). Catalytic Synthesis of Functional Silicon‐Stereogenic Silanes through Candida antarctica Lipase B Catalyzed Remote Desymmetrization of Silicon‐Centered Diols. European Journal of Organic Chemistry. 2013(26). 5814–5819. 28 indexed citations
18.
Wang, Tao, Feng Bao, Yan Liu, et al.. (2008). Effect of Coordination Modes of HL Ligand on the Molecular Architecture of Its Transition Metal Complexes (HL = 5-Methyl-2-Phenyl-4-[(2-o-Tolylamino)-Phenylmethylene]pyrazol-3(2H)-one). Journal of Inorganic and Organometallic Polymers and Materials. 18(3). 420–425. 1 indexed citations
19.
Lü, Xing, Juergen F. Kolb, Shu Xiao, et al.. (2005). Dielectric Strength of Sub-Millimeter Water Gaps Subjected to Microsecond and Sub-Microsecond Voltage Pulses. 600–603. 15 indexed citations
20.
Shull, Robert M., Xing Lü, Ian D. Dubé, et al.. (1996). Humoral immune response limits gene therapy in canine MPS I [letter]. Blood. 88(1). 377–379. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026